Structural heart interventionist
& builder of medical AI
结构性心脏病介入医生
兼医疗 AI 创造者

Grüezi, I'm你好,我是

Dr. Mi Chen医生

MD PhD · Swiss-registered physician (MEBEKO) · fellow at Klinik Hirslanden Zürich · co-founder of CardioAI · Associate Editor, JACC: Case Reports 医学博士 · 瑞士注册医师(MEBEKO) · 苏黎世 Hirslanden 医院 Fellow · CardioAI 联合创始人 · 《JACC: Case Reports》副主编

Helping medicine and machines让医学与机器 speak one language —学会说同一种语言 —— from cath lab to code.从导管室,到代码

The rare mix of an interventionist with 1,700+ structural procedures behind her, a published researcher, and a translator between two worlds. Always precise, never lost in translation. 一位积累了 1700+ 台结构性心脏病手术经验的术者、一位持续发表的研究者、一位游走于两个世界之间的翻译者 —— 三者罕见地集于一身。

About me关于我
About关于我 01
Dr. Mi Chen, structural heart fellow, Klinik Hirslanden Zürich

I'm a structural heart interventionist — TAVI, TEER and transcatheter tricuspid therapies — currently a fellow at Klinik Hirslanden Zürich, after a fellowship at the University Hospital Zurich Heart Center and clinical training at Beijing Anzhen Hospital. Across 1,700+ procedures I've learned exactly where technology helps at the table, and where it gets in the way. 我是一名结构性心脏病介入医生 —— 专注 TAVI、TEER 与经导管三尖瓣治疗,现为苏黎世 Hirslanden 医院结构性心脏病 Fellow,此前曾任苏黎世大学医院心脏中心 Fellow,并在北京安贞医院完成临床训练。1700 多台手术让我确切地知道:技术在手术台上哪里真正有用,哪里只会碍事。

That bedside vantage point is what I bring to AI. I lead AutoClip (NCT07632794), a 1,500-patient multicenter study across Switzerland, Italy and China building real-time AI guidance for mitral repair — work selected as a TCT 2025 innovation project — and I co-founded CardioAI in Zurich to make cardiology and computer science speak each other's language. As European proctor for novel devices such as LuX-Valve Plus (2022–2024), I performed first-in-country implant training across Europe and trained nearly a hundred structural operators. 这份来自手术台的视角,正是我做 AI 的底气。我主持 AutoClip 研究(NCT07632794)—— 一项横跨瑞士、意大利与中国的 1,500 例多中心研究,为二尖瓣修复构建术中实时 AI 引导,相关工作入选 TCT 2025 精选创新项目;我在苏黎世联合创办 CardioAI,让"心脏病学"与"计算机科学"学会说彼此的语言。作为 LuX-Valve Plus 等创新器械的欧洲带教专家(2022–2024),我带教了欧洲多国首例植入,培训了近百名结构性心脏病术者。

Clinical临床Structural heart fellow — Klinik Hirslanden Zürich结构性心脏病 Fellow —— 苏黎世 Hirslanden 医院 · Swiss-registered physician (MEBEKO) · licensed physician, China瑞士注册医师(MEBEKO) · 中国执业医师
Education教育MD & PhD, Capital Medical University (Beijing Anzhen Hospital) · Joint PhD, University Hospital Zurich首都医科大学(北京安贞医院)博士 · 苏黎世大学医院联合培养博士
Academic学术任职Associate Editor, JACC: Case Reports · Faculty, EuroPCR / TCT / PCR London Valves《JACC: Case Reports》副主编 · EuroPCR / TCT / PCR London Valves 学术委员
Research研究25 SCI papers as first/corresponding author · cumulative IF 120+第一/通讯作者 SCI 论文 25 篇 · 累计影响因子 120+
Languages工作语言中文 · English · Deutsch (B2) · 日本語
Recent work代表项目 02

CardioAI: co-founded academic platform, incl. workshop at Swiss AI Weeks 2025 · AutoClip (NCT07632794): 1,500-patient multicenter study of real-time AI segmentation for TEER guidance — sponsor-investigator & PI; sites at Fuwai (Beijing), San Raffaele & San Donato (Milan) and HerzZentrum Hirslanden Zürich, with ETH Zurich · EuroSCORE II GPT: risk assessment with an explicit ethical-use protocol. CardioAI:联合创办的学术平台,含 2025 Swiss AI Weeks 工作坊 · AutoClip(NCT07632794):1,500 例多中心研究,开发 TEER 术中实时 AI 分割引导 —— 陈密医生任发起人与主要研究者,参与中心:北京阜外、米兰 San Raffaele 与 San Donato、苏黎世 Hirslanden 心脏中心,联合 ETH Zurich · EuroSCORE II GPT:配套伦理使用规范的风险评估工具。

I can help you with我能帮你做 03
01

Europe Market-Entry Advisory器械出海 · 欧洲落地顾问

For structural heart device companies entering Europe: operator training design, site relationships, KOL development and launch strategy — built on first-in-country launches in four European countries and 1,700+ procedures. 面向进军欧洲的结构性心脏病器械企业:术者培训体系设计、中心关系、KOL 建设与上市策略 —— 以欧洲四国首例落地与 1700+ 台手术经验为底。

02

Clinical AI Advisory临床 AI 顾问

For imaging-AI startups and health-tech teams: clinical validation design, EU AI Act × MDR readiness, and real workflow fit — from the sponsor-investigator of a 1,500-patient multicenter AI study. 面向影像 AI 初创与医疗科技团队:临床验证设计、EU AI Act × MDR 合规路径、真实工作流契合度 —— 来自一项 1,500 例多中心 AI 研究的发起人。

03

Speaking & Workshops演讲与工作坊

Keynotes and hands-on workshops on AI in cardiovascular care — for conferences, hospital departments and medical schools, in English or Chinese. 面向学术会议、医院科室与医学院的主题演讲与实操工作坊,聚焦心血管领域的 AI 应用,中英文均可。

Products & Programs产品与项目 04
Playbook · English手册 · 英文

Building a Tricuspid Program《三尖瓣项目建设手册》

The operator playbook for launching a TTVR/TEER program — patient screening, imaging workflow, team training and pitfalls. Written from four first-in-country European launches. TTVR/TEER 项目从零到一的术者手册 —— 患者筛选、影像流程、团队培训与避坑清单,源自欧洲四国首例落地实战。

$497 · founding pre-order →创始预订 →
B2B · License企业 · 授权

Operator Training Curriculum术者培训课程体系授权

A complete, field-tested training curriculum for device companies bringing structural heart products to European operators — licensed per cohort, delivered with your clinical team. 为器械企业打造的完整术者培训课程体系(欧洲实战验证),按培训期授权,与贵司临床团队共同交付。

EUR 10–30k / cohort · enquire →洽谈 →
Community · 中文社群 · 中文

结构心脏 · 欧洲前线「结构心脏 · 欧洲前线」

A Chinese-language insider circle for interventional cardiologists — European conference intel, case dissections, and career Q&A from inside the Zurich cath lab. 面向介入医生的中文圈子 —— 欧洲会议一线情报、病例拆解、出海职业问答,来自苏黎世导管室内部视角。

¥799/yr · join waitlist →首批100名 · 候补 →

The Bridge ·《桥》》· The Bridge

China's structural heart devices are going global — and I watch it happen from inside European cath labs. One free letter a month: launches, data, and what actually matters. English, with 中文摘要. 中国结构性心脏病器械正在出海,而我在欧洲导管室内部见证这一切。每月一封免费通讯:新器械落地、关键数据、真正重要的趋势。英文为主,附中文摘要。

No spam. Unsubscribe anytime.拒绝垃圾邮件,可随时退订。

The Monday Briefing周一简报

The week's structural-heart signal, in one email.一封邮件,收下本周结构心的关键信号。

Every Monday: the highest-impact trials, late-breakers and device news of the week — curated from inside the Zurich hybrid room. One email. No noise.每周一:本周影响力最高的临床试验、late-breaking 与器械动态 —— 由苏黎世复合手术室内部策展。一封邮件,绝无噪音。(周报为英文)

Free · English · Unsubscribe anytime. No spam, ever.免费 · 英文 · 随时一键退订。绝不发垃圾邮件。

Let's work一起做点 together.有分量的

Edition版本 © 2026 Dr. Mi Chen · 千觅量子 RYO
Local time当地时间 Zurich — --:-- CET
千里之行 · 觅于毫末